Find therapies in clinical trials near you – page 685

Study on Prednisolone Transfer into Breast Milk and Infant Plasma for Mothers with Rheumatoid Arthritis and Other Inflammatory Conditions

Study on Cabozantinib for Patients with Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer

Study on Cabozantinib for Patients with Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer

Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease

Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Study on Amantadine Hemisulfate for Patients with Unresponsive Wakefulness Syndrome in Intensive and Intermediate Care Units

Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma